yubnub.news
FDA Panel to Review Moderna’s New Flu Vaccine as Approval Decision Approaches
BY MIRABEL ODETAThe U.S. Food and Drug Administration’s advisory panel is preparing to vote on whether the benefits of Moderna’s flu vaccine, mFlusiva, outweigh its potential risks in older adults.…
